APA (7th ed.) Citation

Pawinska-Wasikowska, K., Pawinska-Wasikowska, K., Czogala, M., Czogala, M., Skoczen, S., Skoczen, S., . . . Bukowska-Strakova, K. (2023). Gemtuzumab ozogamicin for relapsed or primary refractory acute myeloid leukemia in children—the Polish Pediatric Leukemia and Lymphoma Study Group experience. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Pawinska-Wasikowska, Katarzyna, et al. Gemtuzumab Ozogamicin for Relapsed or Primary Refractory Acute Myeloid Leukemia in Children—the Polish Pediatric Leukemia and Lymphoma Study Group Experience. Frontiers Media S.A, 2023.

MLA (9th ed.) Citation

Pawinska-Wasikowska, Katarzyna, et al. Gemtuzumab Ozogamicin for Relapsed or Primary Refractory Acute Myeloid Leukemia in Children—the Polish Pediatric Leukemia and Lymphoma Study Group Experience. Frontiers Media S.A, 2023.